158 related articles for article (PubMed ID: 30303435)
1. Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Shamsi HN; Al Suliman SM; Al Rushood AA; Al-Zahrani YA; Al-Mahmood AM; Al Dhibi HA;
Ocul Immunol Inflamm; 2019; 27(8):1296-1304. PubMed ID: 30303435
[No Abstract] [Full Text] [Related]
2. Retinal detachment and uveitis at a tertiary center over 10 years: the King Khaled Eye Specialist Hospital (KKESH) Uveitis Survey Study Group.
Arevalo JF; Lasave AF; Al Ghamdi TA; Gupta V; Kozak I; Al Dhibi HA;
Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1857-1861. PubMed ID: 31177301
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
4. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
5. Uveitis survey in children.
Hamade IH; Al Shamsi HN; Al Dhibi H; Chacra CB; Abu El-Asrar AM; Tabbara KF
Br J Ophthalmol; 2009 May; 93(5):569-72. PubMed ID: 19074918
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Uveitis in a Tertiary Care Referral Institute in Saudi Arabia.
Al Dhibi HA; Al Shamsi HN; Al-Mahmood AM; Al Taweel HM; Al Shamrani MA; Arevalo JF; Gupta V; The Kkesh Uveitis Survey Study Group
Ocul Immunol Inflamm; 2017 Jun; 25(3):388-395. PubMed ID: 26910754
[TBL] [Abstract][Full Text] [Related]
7. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
8. Uveitis in Behçet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group.
Arevalo JF; Lasave AF; Al Jindan MY; Al Sabaani NA; Al-Mahmood AM; Al-Zahrani YA; Al Dhibi HA; ;
Am J Ophthalmol; 2015 Jan; 159(1):177-84.e1-2. PubMed ID: 25448998
[TBL] [Abstract][Full Text] [Related]
9. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
10. Pattern of Uveitis at a Tertiary Eye Hospital in Eastern Province of Saudi Arabia and Comparison with Local Literature.
Alarfaj G; Alahmadi G; Alabdullah H; Al-Khars W; Al-Hammad F
Ocul Immunol Inflamm; 2023 Nov; 31(9):1837-1841. PubMed ID: 36745705
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia.
Al Dhahri H; Al Rubaie K; Hemachandran S; Mousa A; Gikandi PW; Al-Mezaine HS; Abu El-Asrar AM
Ocul Immunol Inflamm; 2015 Aug; 23(4):311-319. PubMed ID: 25058456
[TBL] [Abstract][Full Text] [Related]
12. Current approach in the diagnosis and management of panuveitis.
Bansal R; Gupta V; Gupta A
Indian J Ophthalmol; 2010; 58(1):45-54. PubMed ID: 20029145
[TBL] [Abstract][Full Text] [Related]
13. Causes of uveitis in a tertiary center in Western Saudi Arabia.
Nizamuddin SH; Bawazeer AM
Saudi Med J; 2013 Apr; 34(4):379-87. PubMed ID: 23552591
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of noninfectious intermediate uveitis, posterior uveitis, or panuveitis].
Couret C; Ducloyer JB; Touhami S; Angioi-Duprez K; Rougier MB; Labalette P; Titah C; Cochereau I; Kodjikian L; Mura F; Chiquet C; Weber M; Bodaghi B
J Fr Ophtalmol; 2020 Apr; 43(4):341-361. PubMed ID: 31818505
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
17. Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia.
Al-Qarni A; Abouammoh MA; Almousa AN; Mousa A; Abu El-Asrar AM
Int Ophthalmol; 2019 Feb; 39(2):317-333. PubMed ID: 29318438
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
Das D; Boddepalli A; Biswas J
Indian J Ophthalmol; 2019 Jul; 67(7):1217-1219. PubMed ID: 31238472
[TBL] [Abstract][Full Text] [Related]
19. [Vogt-Koyanagi-Harada disease].
Bonnet C; Daudin JB; Monnet D; Brézin A
J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
[TBL] [Abstract][Full Text] [Related]
20. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
